STAAR Surgical Financial Ratios
NASDAQ: STAAHealth CareOphthalmic GoodsUSD
21.67-0.71 (-3.17%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
STAAR Surgical ratio analysis
STAAR Surgical earned a net margin of -33.6% in FY 2025, down from -6.4% a year earlier. Gross margin was 76.2% compared with a median of 74.5% over the prior 9 years. Return on equity reached -23.4%, meaning STAAR Surgical generated -0.23 dollars of profit for every dollar of shareholders' equity.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
STAAR Surgical financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | — | 72.58 | 60.68 | 163.04 | 660.17 | 114.60 | 284.18 | — | — |
| Price / sales | 4.89 | 3.79 | 4.70 | 9.73 | 18.70 | 22.10 | 10.19 | 10.74 | 7.01 | 5.31 |
| Price / book | 3.40 | 2.99 | 3.92 | 6.93 | 16.48 | 18.32 | 9.57 | 10.05 | 14.80 | 11.54 |
| Gross margin | 76.2% | 76.3% | 78.4% | 93.3% | 77.5% | 72.4% | 74.5% | 73.8% | 70.9% | 70.8% |
| Operating margin | -38.3% | -4.0% | 8.7% | 18.3% | 14.5% | 4.1% | 7.9% | 5.3% | -4.0% | -15.4% |
| Net margin | -33.6% | -6.4% | 6.6% | 16.6% | 11.9% | 3.6% | 9.4% | 4.0% | -2.4% | -14.7% |
| Free cash flow margin | -16.7% | -2.4% | -1.1% | 7.4% | 13.2% | 7.7% | 10.5% | 8.5% | 2.0% | -2.6% |
| Return on equity (ROE) | -23.4% | -5.1% | 5.5% | 11.8% | 10.5% | 3.0% | 8.8% | 3.8% | -5.0% | -32.0% |
| Return on assets (ROA) | -17.8% | -4.0% | 4.4% | 9.5% | 8.0% | 2.3% | 6.8% | 3.0% | -3.1% | -18.5% |
| Current ratio | 4.55 | 5.23 | 5.62 | 6.03 | 5.56 | 5.25 | 5.07 | 5.47 | 2.82 | 2.35 |
| Revenue growth | -23.7% | -2.6% | 34.7% | 3.9% | 41.0% | 8.8% | 21.2% | 36.8% | 9.9% | 6.9% |
| EPS growth | — | -195.3% | -46.3% | 42.9% | 366.7% | -60.0% | 172.7% | — | — | — |